Vaccinex, Inc. Proceeds from Contributed Capital
Vaccinex, Inc. (VCNX) reported Proceeds from Contributed Capital of $11.50 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromContributedCapital · last filed 2025-04-15
- Vaccinex, Inc. proceeds from contributed capital for the quarter ending 2020-03-31 was $11.50M.
- Vaccinex, Inc. proceeds from contributed capital for the quarter ending 2018-12-31 was $0.00.
- Vaccinex, Inc. proceeds from contributed capital for the quarter ending 2018-09-30 was $0.00.
- Vaccinex, Inc. proceeds from contributed capital for the quarter ending 2018-06-30 was $4.00M.
- Vaccinex, Inc. proceeds from contributed capital for fiscal 2018 was $12.00M.
| Period end | Proceeds from Contributed Capital | Proceeds from Contributed Capital 3 month | Proceeds from Contributed Capital 6 month | Proceeds from Contributed Capital 9 month | Proceeds from Contributed Capital 12 month |
|---|---|---|---|---|---|
| 2020-03-31 | $11.50M 10-Q · filed 2020-08-14 | ||||
| 2020-03-27 | $11.50M 10-K · filed 2025-04-15 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $0.00 derived: sum of 2 quarters · filed 2020-03-09 | $4.00M derived: sum of 3 quarters · filed 2020-03-09 | $12.00M 10-K · filed 2020-03-09 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $4.00M derived: sum of 2 quarters · filed 2019-11-12 | $12.00M 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $12.00M 10-Q · filed 2019-08-14 | |||
| 2018-03-31 | $8.00M 10-Q · filed 2019-05-15 | ||||
| 2017-12-31 | $12.00M 10-Q · filed 2019-11-12 |